Company intelligence / Profile preview
Daiichi Sankyo Healthcare
Chuo-ku, Tokyo, Japandaiichisankyo-hc.co.jp ↗
- Ownership
- Private
- Employees
- ~612
- Development stage
- Other
01
Overview
Daiichi Sankyo Healthcare is a leading Japanese company in the over-the-counter (OTC) and consumer health sector. A wholly-owned subsidiary of Daiichi Sankyo, it was formed in 2006 by merging the healthcare divisions of Daiichi Pharmaceutical and Sankyo. The company holds top market shares in Japan for pain relief, gastrointestinal treatments, and medicated skincare through household brands like Loxonin S and Transino.
- Therapeutic areas
- ImmunologyNeurologyDermatologyInfectious DiseasesPulmonologyGastroenterology
- Modalities
- Small moleculePeptidesTopical formulation
- Industry
- Pharma
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Takeda Consumer HealthcareMitsubishi Tanabe Pharma
Beyond the preview
Go deeper on Daiichi Sankyo Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daiichi Sankyo Healthcare.